Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
Covid-19 Vaccine Possible by November Despite Concerns: Mark Meadows
Posted
September 8, 2020
Views
16,062
Likes
42
Comments
104
Engagement
September 8, 2020
16,062
42
104
0.91%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
You’re on September 8, 2020. Earlier episodes are to the left, later ones to the right — the row keeps loading as you go. Click any card to open it.
Sep 8, 20202:11Now PlayingWhite House Chief of Staff Mark Meadows is doubling down on the possibility of a vaccine by the election day despite concern over its readiness.
"I'm very optimistic that we will have something by the end of October," said Meadows Tuesday while talking to reporters on the White House driveway.
"If you're looking at the end of October as Election Day, I would agree with the president that the progress to date has been extremely encouraging."
This comes after Sen. Kamala Harris, the Democrats' vice presidential candidate, said she “would not trust his word” on getting the vaccine. “I would trust the word of public health experts and scientists, but not Donald Trump,” Harris said.
Democratic presidential candidate Joe Biden amplified Harris' comments Monday after he was asked if he would get a vaccine for COVID-19, the disease caused by the novel coronavirus. Biden said he would take a vaccine but wants to see what the scientists have to say, too.
"This is the political season, they're going to criticize anything that the president is involved with," said Meadows.
"I can tell you it's good science and good doctors and great companies that are actually working hand in glove to try to deliver something in record speed."
Under a program President Donald Trump calls “Operation Warp Speed,” the goal is to have 300 million doses of a coronavirus vaccine in stock by January.
He has spent hundreds of billions of dollars on what amounts to a huge gamble since vaccine development usually takes years.
Concerns exist about political influence over development of a vaccine, and whether one produced under this process will be safe and effective.
Dr. Anthony Fauci, the government’s top infectious-disease expert and a member of the White House coronavirus task force, told CNN last week that it is unlikely but “not impossible” that a vaccine could win approval in October, instead of November or December.
Fauci added that he's “pretty sure” a vaccine would not be approved for Americans unless it was both safe and effective.
Stephen Hahn, commissioner of the Food and Drug Administration, has said the agency would not cut corners as it evaluates vaccines, but would aim to expedite its work. He told the Financial Times last week that it might be “appropriate" to approve a vaccine before clinical trials were complete if the benefits outweighed the risks.
Subscribe to our YouTube channel
QUICKTAKE ON SOCIAL:
Follow QuickTake on Twitter: twitter.com/quicktake
Like QuickTake on Facebook: facebook.com/quicktake
Follow QuickTake on Instagram: instagram.com/quicktake
Subscribe to our newsletter
Email us at quicktakenews@gmail.com
QuickTake by Bloomberg is a global news network delivering up-to-the-minute analysis on the biggest news, trends and ideas for a new generation of leaders.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
